Pharmaceutical company warehouse morning meeting to promote management
Release time:
2023-01-12
a.m. 8 , on the platform of the warehouse of the pharmaceutical company, Ni Zhiquan, director of the warehouse department, arranged and implemented the work of the day. Jiang Xiaohua, director of quality, stressed the recent safety precautions. after the meeting, the team leaders returned to their posts to start the work of the day. This is a scene from the morning meeting of the storage department of the pharmaceutical company.
2016 9# July, the pharmaceutical company carried out the technical reform of warehouse logistics electronic labels. In order to do a good job in the connection of all aspects of warehouse work and facilitate the coordination of work, the storage department of the pharmaceutical company implemented the morning meeting system. In the few minutes before the daily work, the person in charge or the warehouse director arranged the work, solved the daily problems and emphasized the safety precautions. 2021 , according to the actual work, the morning meeting of the storage department was changed from daily to every Monday, 35th.
Ni Zhiquan introduced that the warehouse of the pharmaceutical company has four floors. According to the different Chinese and Western medicines and dosage forms, there are more than a dozen teams and groups. There will be many inconveniences in work coordination. Sometimes it will take half a day to notify one thing and each team to say it again, and there will be poor coordination, which will affect work efficiency to a certain extent. After the implementation of the morning meeting system, the employees will hold a morning meeting on the platform as soon as they arrive at the company, arrange the work content of the day, and finish everything at the meeting, find out and solve the problems in time, so as to better carry out the work and promote the management of employees. Although we were not used to it when it was first implemented, after a period of implementation, most of the problems could be timely fed back and solved at the meeting. We all felt that the work was better carried out, the management was smoother and the work efficiency was improved. Now everyone is used to having a meeting at the company and then putting into a busy day's work.
Jiang Xiaohua is in charge of the storage department. He will attend every morning meeting. He said that since the implementation of the morning meeting system, the mental outlook and work efficiency of employees have improved significantly. The morning meeting is the first step in the daily work. It defines the daily work objectives. It not only grasps the work trends of each post in time, finds and solves the existing problems, but also further improves the planning of each work to ensure the orderly, efficient and high-quality completion of each work. On-site emphasis on rules and regulations, safety precautions, etc., face-to-face publicity, further strengthen staff awareness, improve management effectiveness; Each team leader summarized yesterday's work situation, put forward the problems that need to be solved in coordination, understand the work content of other teams, strengthen the contact between teams, further improve work efficiency and strengthen the team consciousness of each team.
(ReporterNi Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page